Find the latest TOP Ships Inc. (TOPS) stock quote, history, news and other vital information to help you with your stock trading and investing. Atossa Therapeutics, Inc. (ATOS) Interactive Stock Chart ... Atossa Therapeutics, Inc. (ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on Atossa Genetics: Expect More Near-Term Positive Catalysts ... Mar 18, 2019 Atossa Genetics News: FDA Approval Sends ATOS Stock ... Mar 14, 2019
Atossa Therapeutics, Inc. Common Stock (ATOS) SEC Filings ...
ATOS: Atossa Genetics Inc broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Recent News for $ATOS | Atossa Genetics Inc ... Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Shareholders Highlighting Key Accomplishments and Strategy for 2020 Jan 6 Atossa Genetics Announces Corporate Name Change to Atossa Therapeutics, Inc. Investors - Atos
Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19.
View Atossa Genetics Inc ATOS investment & stock information. Get the latest Atossa Genetics Inc ATOS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ATOS on TradingView ATOS on StockCharts.com Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. ATOS closed up 25.84 percent on Friday, June 5, 2020, on 2.72 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
ATOS: Atossa Genetics Inc - Brokerage Recommendations ...
ATOS Atossa Therapeutics, Inc. Common Stock. Data is currently not available. $3.36. 0.69 (25.84%) DATA AS OF Jun 05, 2020. Latest News. ATRA Abuzz, ATOS' COVID-19 …
24 Apr 2020 As cloud-based solutions and other key technologies enable rapid changes in people's work and personal lives brought about by COIVD-19, Atos
ATOS on TradingView ATOS on StockCharts.com Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. ATOS Stock Price & Charts | Atossa Therapeutics Description: Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The clinical-Stage Programs of the company includes delivery of therapeutics through microcatheters which TOP Ships Inc. (TOPS) Stock Price, Quote, History & News ... Find the latest TOP Ships Inc. (TOPS) stock quote, history, news and other vital information to help you with your stock trading and investing. Atossa Therapeutics, Inc. (ATOS) Interactive Stock Chart ...